Kowa Pharmaceuticals America

Denali and Mont Blanc Phase 3 studies advance Kowa's ophthalmology pipeline

April 3, 2026

Placeholder press-release body. Final copy to be supplied from the manuscript.

Explore Our Products and Pipeline